Transcript : Cara Therapeutics, Inc., This autumn 2022 Earnings Name, Mar 06, 2023

Good afternoon, my identify is Josh, and I shall be your convention facilitator. I wish to welcome everybody to the Cara Therapeutics Fourth Quarter and Full 12 months 2022 Monetary Outcomes and Replace…

S&P Capital IQ 2023

All information about CARA THERAPEUTICS, INC.

Analyst Suggestions on CARA THERAPEUTICS, INC.

Gross sales 2022 53,5 M

Internet revenue 2022 -74,5 M

Internet money 2022 160 M

P/E ratio 2022 -7,35x
Yield 2022
Capitalization 538 M
538 M
EV / Gross sales 2022 7,06x
EV / Gross sales 2023 3,86x
Nbr of Staff 84
Free-Float 83,8%


Period :

Interval :

Cara Therapeutics, Inc. Technical Analysis Chart | MarketScreener

Technical evaluation tendencies CARA THERAPEUTICS, INC.

Quick Time period Mid-Time period Lengthy Time period
Tendencies Bearish Impartial Impartial

Revenue Assertion Evolution



Imply consensus BUY
Variety of Analysts 8
Final Shut Worth 10,02 $
Common goal worth 23,13 $
Unfold / Common Goal 131%

Supply hyperlink